ADIM
CDNA icon

Alpha DNA Investment Management’s CareDx CDNA Stock Holding History

Alpha DNA Investment Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,983
Closed -$406K – 40
2024
Q4 		$406K Buy
18,983
+3,880
+26% +$94.4K 0.15% 170
2024
Q3 		$472K Buy
+15,103
New +$376K 0.18% 128
2021
Q2 		– Sell
-64
Closed -$3K – 187
2021
Q1 		$3K Sell
64
-30
-32% -$2.33K ﹤0.01% 457
2020
Q4 		$6K Buy
+94
New +$5.45K 0.01% 343

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Alpha DNA Investment Management's CDNA Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of CareDx (CDNA) in Q1 2025, closing a stake of 18,983 shares — an estimated $406K sold.

Alpha DNA Investment Management first reported a position in CDNA in Q4 2020 and held it in 4 quarters. The position peaked at $472K in Q3 2024. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 18,983 CareDx shares in Q1 2025, an estimated $406K.
  • Alpha DNA Investment Management first reported a position in CareDx in Q4 2020 and held it in 4 quarters.
  • Alpha DNA Investment Management's CareDx position peaked at $472K in Q3 2024.
  • 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.